Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!
Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers !
Shipping Price Reduction for EU Regions
Kat. Nr. | Arten | Produktbeschreibung | Struktur | Reinheit | Merkmal |
---|---|---|---|---|---|
CTF-H5113 | Human | Human CTGF / CCN2 Protein, Tag Free | ![]() |
![]() ![]() |
|
GTF-H5253 | Human | Human CTGF / CCN2 Protein, Fc Tag | ![]() |
![]() ![]() |
|
GTF-R52H4 | Rhesus macaque | Rhesus macaque CTGF / CCN2 Protein, His Tag | ![]() |
![]() ![]() |
|
CTF-M52Hc | Mouse | Mouse CTGF / CCN2 Protein, His Tag | ![]() |
![]() ![]() |
|
CTF-H52H5 | Human | Human CTGF / CCN2 Protein, His Tag | ![]() |
![]() ![]() |
|
CTF-H82E6 | Human | Biotinylated Human CTGF / CCN2 Protein, His,Avitag™ (recommended for biopanning) | ![]() |
![]() ![]() |
Loaded Monoclonal Anti-Human CTGF Antibody, Human IgG1 on AHC Biosensor, can bind Mouse CTGF, His Tag (Cat. No. CTF-M52Hc) with an affinity constant of 2.46 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Penicillamine | Approved | Valeant | Distamine, Pemine, Trisorcin, Cuprimine, Cupramine, Trolovol | United States | Hepatolenticular Degeneration; Cystinuria; Arthritis, Rheumatoid | Valeant Pharmaceuticals International Inc | 1970-12-04 | Heavy Metal Poisoning; Arthritis, Rheumatoid; Hepatolenticular Degeneration; Cystinuria; Lead Poisoning | Details | |
Penicillamine | Approved | Valeant | Distamine, Pemine, Trisorcin, Cuprimine, Cupramine, Trolovol | United States | Hepatolenticular Degeneration; Cystinuria; Arthritis, Rheumatoid | Valeant Pharmaceuticals International Inc | 1970-12-04 | Heavy Metal Poisoning; Arthritis, Rheumatoid; Hepatolenticular Degeneration; Cystinuria; Lead Poisoning | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Pamrevlumab | FG-3019 | Phase 3 Clinical | Fibrogen Inc | Diabetes Mellitus, Type 2; Idiopathic Pulmonary Fibrosis; Pancreatic Neoplasms; Coronavirus Disease 2019 (COVID-19); Liver Cirrhosis; Glomerulosclerosis, Focal Segmental; Muscular Dystrophy, Duchenne; Diabetic Nephropathies; Diabetes Mellitus | Details |
OLX-10010 | cp-asiCTGF; OLX-101A; OLX-10010; BMT-101; OLX-101 | Phase 2 Clinical | Olix Pharmaceuticals Inc | Pulmonary Fibrosis; Wet Macular Degeneration; Cicatrix, Hypertrophic; Macular Degeneration | Details |
SHR-1906 | SHR-1906 | Phase 2 Clinical | Guangdong Hengrui Pharmaceutical Co Ltd | Idiopathic Pulmonary Fibrosis | Details |
PRS-220 | PRS-220 | Phase 1 Clinical | Pieris Pharmaceuticals | Idiopathic Pulmonary Fibrosis | Details |
LEM-S401 | LEM-S401; LEMS401 | Phase 1 Clinical | Lemonex Inc | Cicatrix | Details |
Pamrevlumab | FG-3019 | Phase 3 Clinical | Fibrogen Inc | Diabetes Mellitus, Type 2; Idiopathic Pulmonary Fibrosis; Pancreatic Neoplasms; Coronavirus Disease 2019 (COVID-19); Liver Cirrhosis; Glomerulosclerosis, Focal Segmental; Muscular Dystrophy, Duchenne; Diabetic Nephropathies; Diabetes Mellitus | Details |
OLX-10010 | cp-asiCTGF; OLX-101A; OLX-10010; BMT-101; OLX-101 | Phase 2 Clinical | Olix Pharmaceuticals Inc | Pulmonary Fibrosis; Wet Macular Degeneration; Cicatrix, Hypertrophic; Macular Degeneration | Details |
SHR-1906 | SHR-1906 | Phase 2 Clinical | Guangdong Hengrui Pharmaceutical Co Ltd | Idiopathic Pulmonary Fibrosis | Details |
PRS-220 | PRS-220 | Phase 1 Clinical | Pieris Pharmaceuticals | Idiopathic Pulmonary Fibrosis | Details |
LEM-S401 | LEM-S401; LEMS401 | Phase 1 Clinical | Lemonex Inc | Cicatrix | Details |
This web search service is supported by Google Inc.